Chapter 5

Immunotherapy

Solange Gil, Dias J., Lourenço A.M., Leal R. and Tavares L.

Abstract

The relationship between a host and a pathogen is dynamic, and its outcome depends on the virulence of the invader and the relative degree of resistance or susceptibility of the host at that particular occasion. Fortunately, only an infinitesimal minority of microorganisms are able to avoid the host defenses and eventually cause disease. The host has evolved multifaceted strategies for defending itself against invasion, and pathogens have evolved their own strategies of counter-attack for host defenses pointing us to the co-evolution of “defense” and “attack” mechanisms. Many factors determine the outcome of the bacterium-host relationship. In this battle, the development of antibiotics was a game-changing turn. Unfortunately, more and more strains of pathogenic bacteria have become antibiotic resistant. One of this century’s greatest medical challenges is the rapid emergence of multidrug-resistant pathogens. Discovery of new antimicrobial classes and alternative therapeutic options would be especially welcomed in this era. The fact that some bacterial infections might no longer be successfully treated with antibiotics, combined with an increasing population density and mobility, justifies the urgent demands for the development of novel treatments, of which immunotherapies are considered most promising. Immuno modulatory regimens offer an attractive approach as they often have fewer side effects than existing drugs, including less potential for creating resistance in microbial diseases. Nowadays, treating emerging chronic and multidrug-resistant infectious, autoimmune and oncological diseases through reinforcement of the immune system became a major priority.

Total Pages: 97-148 (52)

Purchase Chapter  Book Details

RELATED BOOKS

.COVID-19: Current Challenges and Future Perspectives.
.Tuberculosis: A Clinical Practice Guide  .
.The COVID-19 Pandemic: Epidemiology, Molecular Biology and Therapy.
.Frontiers in Clinical Drug Research- HIV.